An Australian company that clinched the first US clearance for its at-home Covid-19 test kit has collapsed into liquidation after a sale to a competitor fell through.
Covid-19 test maker Ellume Ltd.’s sale to Hough Consolidated Pty Ltd. unraveled this week, and the company is now winding down operations, according to a statement. Hough had agreed to buy the company in December for $38 million (A$56 million), but the deal fell apart after Hough made repeated requests to extend deadlines tied to the agreement.
The rapid Covid test maker has struggled for months despite investment from both Australia ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.